Tabelecleucel for Epstein-Barr Virus-Positive Post-Transplant Lymphoproliferative Disease After Failure of Rituximab ± Chemotherapy Following Solid Organ or Allogeneic Hematopoietic Cell Transplant (ALLELE)

被引：0

作者：

Mahadeo, K. M. ^{[1
]}

Baiocchi, R. ^{[2
]}

Beitinjaneh, A. ^{[3
]}

Chaganti, S. ^{[4
]}

Choquet, S. ^{[5
]}

Dierickx, D. ^{[6
]}

Dinavahi, R. ^{[7
]}

Gamelin, L. ^{[7
]}

Ghobadi, A. ^{[8
]}

Guzman-Becerra, N. ^{[7
]}

Joshi, A. ^{[7
]}

Mehta, A. ^{[7
]}

Nikiforow, S. ^{[9
]}

Reshef, R. ^{[10
]}

Prockop, S. ^{[11
]}

机构：

[1] Duke Univ, Durham, NC USA

[2] Ohio State Univ, James Comprehens Canc Ctr, Columbus, OH 43210 USA

[3] Univ Miami, Jackson Mem Hosp, Miami, FL 33136 USA

[4] Univ Hosp Birmingham, Ctr Clin Haematol, Birmingham, W Midlands, England

[5] Hosp Pitie Salpetriere, Paris, France

[6] Univ Hosp Leuven, Leuven, Belgium

[7] Atara Biotherapeut, San Francisco, CA USA

[8] Washington Univ, Div Oncol, St Louis, MO 63110 USA

[9] Dana Farber Canc Inst, Boston, MA 02115 USA

[10] Columbia Univ, Med Ctr, New York, NY USA

[11] Boston Childrens Hosp, Dana Farber Canc Inst, Boston, MA USA

来源：

关键词：

D O I：

暂无

中图分类号：

R61 [外科手术学];

学科分类号：

摘要：

526

引用

页码：S589 / S589

页数：1